Abstract:Hypertension, a common cardiovascular disease, is primarily characterized by vascular remodeling. Recent extensive research has led to significant progress in understanding its mechanisms. Traditionally, vascular remodeling has been described as a unidirectional process in which blood vessels undergo adaptive remodeling or maladaptive remodeling. Adaptive remodeling involves an increase in vessel diameter in response to increased blood flow, while maladaptive remodeling refers to the narrowing or thickening of blood vessels in response to pathological conditions. However, recent research has revealed that vascular remodeling is much more complex. It is now understood that vascular remodeling is a dynamic interplay between various cellular and molecular events. This interplay process involves different cell types, including endothelial cells, smooth muscle cells, and immune cells, as well as their interactions with the extracellular matrix. Through these interactions, blood vessels undergo intricate and dynamic changes in structure and function in response to various stimuli. Moreover, vascular remodeling involves various factors and mechanisms such as the renin-angiotensin-aldosterone system (RAS), oxidative stress, inflammation, the extracellular matrix (ECM), sympathetic nervous system (SNS) and mechanical stress that impact the arterial wall. These factors may lead to vascular and circulatory system diseases and are primary causes of long-term increases in systemic vascular resistance in hypertensive patients. Additionally, the presence of stem cells in adventitia, media, and intima of blood vessels plays a crucial role in vascular remodeling and disease development. In the future, research will focus on examining the underlying mechanisms contributing to hypertensive vascular remodeling to develop potential solutions for hypertension treatment. This review provides us with a fresh perspective on hypertension and vascular remodeling, undoubtedly sparking further research efforts aimed at uncovering more potent treatments and enhanced preventive and control measures for this disease.

Cellular and Molecular Mechanisms Underlying Arterial Baroreceptor Remodeling in Cardiovascular Diseases and Diabetes

Angiotensin II-Superoxide Signaling and Arterial Baroreceptor Function in Type-1 Diabetes Mellitus

Functional Changes in Baroreceptor Afferent, Central and Efferent Components of the Baroreflex Circuitry in Type 1 Diabetic Mice (OVE26)

Baroreflex Function in Cardiovascular Disease

Angiotensin II-superoxide-NFκB signaling and aortic baroreceptor dysfunction in chronic heart failure.

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Angiotensin II-NADPH Oxidase-Derived Superoxide Mediates Diabetes-Attenuated Cell Excitability of Aortic Baroreceptor Neurons.

Arterial Baroreflex Dysfunction Promotes Atherosclerosis in Rats

Elevated Angiotensin Ii in Rat Nodose Ganglia Primes Diabetes-Blunted Arterial Baroreflex Sensitivity: Involvement of Nadph Oxidase-Derived Superoxide

Molecular Mechanisms Underlying Vascular Remodeling in Hypertension

Baroreceptor reflex in heart failure

Arterial Baroreflex Function And Left Ventriculair Hytypertrophy

Effect Of Angiotensin Ii On Voltage-Gated Sodium Currents In Aortic Baroreceptor Neurons And Arterial Baroreflex Sensitivity In Heart Failure Rats

Blunted Excitability of Aortic Baroreceptor Neurons in Diabetic Rats: Involvement of Hyperpolarization-Activated Channel

ACE2/Ang-(1–7) signaling and vascular remodeling

Mechanosensitive Ion Channels in Blood Pressure-Sensing Baroreceptor Neurons.

Reduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats.

Neural reflex regulation of arterial pressure in pathophysiological conditions: interplay among the baroreflex, the cardiopulmonary reflexes and the chemoreflex

Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases

Modeling the physiological roles of the heart and kidney in heart failure with preserved ejection fraction during baroreflex activation therapy

Mechanobiology in Vascular Remodeling